Pro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 5,381 shares of the stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $41.64, for a total value of $224,064.84. Following the transaction, the director now owns 319,752 shares of the company's stock, valued at $13,314,473.28. This represents a 1.66 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Pro-Dex Price Performance
Shares of PDEX stock opened at $41.79 on Wednesday. Pro-Dex, Inc. has a 52 week low of $16.18 and a 52 week high of $59.60. The stock has a market capitalization of $136.24 million, a PE ratio of 27.14 and a beta of 0.56. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.94 and a current ratio of 3.41. The stock's fifty day moving average is $47.75 and its 200-day moving average is $34.11.
Analyst Ratings Changes
A number of brokerages recently issued reports on PDEX. StockNews.com upgraded shares of Pro-Dex from a "buy" rating to a "strong-buy" rating in a research report on Saturday, December 14th. Ascendiant Capital Markets lifted their target price on shares of Pro-Dex from $30.00 to $52.00 and gave the company a "buy" rating in a research note on Monday, November 11th.
Read Our Latest Analysis on PDEX
Institutional Investors Weigh In On Pro-Dex
A number of hedge funds have recently added to or reduced their stakes in the stock. Ritholtz Wealth Management acquired a new position in shares of Pro-Dex during the fourth quarter worth approximately $572,000. Renaissance Technologies LLC raised its position in Pro-Dex by 7.9% in the 2nd quarter. Renaissance Technologies LLC now owns 12,240 shares of the medical instruments supplier's stock worth $240,000 after purchasing an additional 900 shares during the last quarter. FMR LLC lifted its holdings in Pro-Dex by 34.9% during the 3rd quarter. FMR LLC now owns 3,973 shares of the medical instruments supplier's stock worth $119,000 after buying an additional 1,028 shares in the last quarter. Geode Capital Management LLC boosted its position in Pro-Dex by 9.1% in the 3rd quarter. Geode Capital Management LLC now owns 27,435 shares of the medical instruments supplier's stock valued at $819,000 after buying an additional 2,296 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in shares of Pro-Dex by 5.1% in the 2nd quarter. Dimensional Fund Advisors LP now owns 63,036 shares of the medical instruments supplier's stock valued at $1,238,000 after buying an additional 3,067 shares during the period. Institutional investors own 15.28% of the company's stock.
About Pro-Dex
(
Get Free Report)
Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
